SEI INVESTMENTS CO

Position in RLMD — Relmada Therapeutics, Inc.

CIK 350894 OAKS, PA

Position in RLMD

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$480,075

-$679,558 QoQ

Shares Held

69,375

-58.4% QoQ

Ownership

0.065%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#72

of 126 holders

Holding Since

Dec 2022

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

SEI INVESTMENTS CO holds $1,273,690,748 across 210 Biotechnology names. RLMD ranks #119 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ARGX	Argenx SE	255,073	$236,649,076
2	INSM	INSMED Inc	1,015,870	$108,312,059
3	VRTX	Vertex Pharmaceuticals Inc / Ma	129,981	$64,565,461
4	EXEL	Exelixis, Inc.	1,166,715	$63,480,962
5	ASND	Ascendis Pharma A/S	237,869	$63,444,419
6	INCY	Incyte Corp	498,013	$56,454,752
7	HALO	Halozyme Therapeutics, Inc.	551,116	$43,135,848
8	REGN	Regeneron Pharmaceuticals, Inc.	60,441	$37,687,380

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$480,075	69,375	-58.4%	Shares	Sole	2026-08-14
2026-03-31	$1,159,633	166,614	+68.4%	Shares	Sole	2026-05-13
2025-12-31	$478,000	98,965	+173.2%	Shares	Sole	2026-02-13
2025-03-31	$9,782	36,230	0.0%	Shares	Sole	2025-05-14
2024-12-31	$18,839	36,230	-0.2%	Shares	Sole	2025-02-11
2024-09-30	$117,676	36,320	0.0%	Shares	Sole	2024-11-12
2024-06-30	$108,960	36,320	0.0%	Shares	Sole	2024-08-13
2024-03-31	$168,887	36,320	0.0%	Shares	Sole	2024-05-07
2023-12-31	$150,364	36,320	+0.2%	Shares	Sole	2024-02-14
2023-09-30	$108,690	36,230	0.0%	Shares	Sole	2023-11-14
2023-06-30	$89,125	36,230	-2.0%	Shares	Sole	2023-08-11
2023-03-31	$83,549	36,969	-63.5%	Shares	Sole	2023-05-12
2022-12-31	$353,694	101,345	—	Shares	Sole	2023-02-10
No filing history on record for this holder in this stock.